IBSA USA
Charlotte Donati, PACS, currently serves as the Executive Specialty Sales Representative at IBSA USA, where notable achievements include receiving the 2023 Veloce Award (Presidents Club) and ranking #2 out of 76 representatives. Additionally, Charlotte holds the role of Regional Field Trainer for the MidAtlantic and is a Prior Authorization Certified Specialist. Prior experience encompasses legal roles, including Lead Litigation Paralegal at Menn Law Firm, compliance management at Krause Financial Services, and various positions supporting attorneys at law firms such as Tin, Fulton, Walker & Owen, and Tippens & Zurosky. Charlotte obtained a Bachelor of Arts in Criminal Justice and Criminology from the University of North Carolina at Charlotte.
This person is not in any teams
IBSA USA
IBSA USA is the subsidiary of IBSA Group, the largest privately owned pharmaceutical company in Switzerland. IBSA is committed to improving patient quality of life through research, innovation, and the development of effective drugs and cutting-edge technologies. IBSA USA markets two unique levothyroxine formulations in the U.S. for the treatment of hypothyroidism: Tirosint® (levothyroxine sodium) capsules and Tirosint®-SOL (levothyroxine sodium) oral solution. IBSA also markets Licart™ (diclofenac epolamine) topical system 1.3%, the only once-a-day topical nonsteroidal anti-inflammatory (NSAID) available in the U.S. to treat acute pain due to minor strains, sprains, and contusions. IBSA is focused on the health and well-being of patients and driven by the desire to bring therapeutic alternatives to as many people as possible. IBSA Group bases its philosophy on four sustainable pillars: Person, Innovation, Quality, and Responsibility. For more information about Tirosint, Tirosint-SOL, or Licart, including Full Prescribing Information, go to each brand’s respective website.